乳腺癌耐药蛋白的研究进展

乳腺癌耐药相关蛋白(BCRP/ABCG2)是新近发现的ATP结合盒(Adenosine triphosphate-binding cassette,ABC)膜转运蛋白超家族成员。它作为细胞膜上的药物排出泵,可以将一系列细胞毒药物转运至胞外从而介导肿瘤细胞多药耐药。在很多血液肿瘤和实体瘤中均检测到ABCG2表达。ABCG2在肿瘤的多药耐药上发挥重要作用。本文对ABCG2的发现、基因表达特征、与造血干细胞分化的关系、转运底物及其耐药逆转和临床意义等方面的研究进展进行综述。     

ABC细胞膜转运蛋白及其介导的细胞多药耐药研究进展

ABC细胞膜转运蛋白是一个能转运多种底物的蛋白质家族,其在宿主对异物的防御机制和肿瘤细胞对抗癌药物的耐药性中发挥重要作用。ABC转运蛋白能将已进人细胞的外源性物质从胞内泵出胞外,是造成肿瘤细胞多药耐药的主要原因,其基因表达水平与细胞内药物浓度和耐药程度密切相关。近年来,肿瘤细胞多药耐药性研究炙手可热。我们简要综述ABC细胞膜转运蛋白的特点、分布、表达及其介导的细胞多药耐药方面的研究进展。     

肿瘤多药耐药:机制及逆转剂

肿瘤细胞多药耐药性(multidrug resistance,MDR)的产生是临床上导致肿瘤化疗失败的主要原因之一,因此寻找高效低毒的MDR逆转剂已成为肿瘤药物开发领域的热点。MDR的作用机制主要包括P-糖蛋白、多药耐药相关蛋白、乳腺癌耐药蛋白、肺耐药相关蛋白等等。多药耐药逆转剂包括钙离子通道阻滞剂、维拉帕米及其衍生物等等。本文主要介绍了MDR的作用机制以及肿瘤多药耐药逆转剂的研究进展。     

STAT3与在肿瘤耐药中的研究进展

STAT3是信号转导与转录活化蛋白(STATs)家族的重要一员,是一种存在于胞浆并在激活后能够转入核内与DNA结合的蛋白家族,具有信号转导和转录调控双重功能。STAT3在多种肿瘤组织与细胞系中异常表达,并与肿瘤的增殖分化、细胞凋亡密切相关。肿瘤耐药是其治疗失败的重要原因,STAT3能够通过多种途径介导肿瘤耐药。因而,STAT3在近年的抗肿瘤研究中备受关注,成为肿瘤治疗的良好靶点,由传统药物与STAT3抑制剂组成的新型治疗方案使得肿瘤患者大大受益。然而,STAT3介导肿瘤耐药的机制还不是很明确,需要进一步研究。本文就近年来一些化疗药物和靶向药物耐药的发生,对STAT3介导耐药的作用进行综述。     

肿瘤耐药相关信号传导通路研究进展

<正>临床上,化疗在肿瘤治疗中占有重要地位,但化疗也易出现肿瘤细胞耐药现象。耐药分为原药耐药(PDR)和多药耐药(MDR),原药耐药为肿瘤细胞对已使用过的药物产生了耐药作用;而多药耐药是指肿瘤细胞在对一种化疗药物产生耐药后,出现对其他不同作用机制的药物也产生耐药。肿瘤细胞多药耐药是决定肿瘤患者化疗成功与否的关键。多药耐药已出现在多种肿瘤疾病,如乳腺癌、食管癌、鼻咽癌、     

上皮细胞黏附分子增强细胞间紧密连接促进乳腺癌细胞耐药

乳腺癌是致死率很高的恶性肿瘤,由ABCG2 (ATP-binding cassette G2)介导的多药耐药(multidrug resistance,MDR)是导致其化疗失败的重要原因,探讨ABCG2介导的耐药机制并探寻其关键分子是当前亟待解决的难题。上皮细胞黏附分子(epithelial cell adhesion molecule,EpCAM)参与多种肿瘤耐药,且与乳腺癌MDR密切相关,但它在ABCG2介导的乳腺癌耐药中的作用尚未阐明。本研究目的在于探究EpCAM对于ABCG2介导的乳腺癌细胞的多药耐药的调节作用及其机制。CCK8细胞毒性结果证实,相对于人乳腺癌药物敏感株MCF-7,耐药株MCF-7/MX对米托蒽醌(mitoxantrone,MX)的耐药性显著增强;Western 印迹结果显示,与MCF-7相比,MCF-7/MX细胞中ABCG2高表达,EpCAM表达上调。siRNA法敲低MCF-7/MX细胞中EpCAM可下调其ABCG2表达,并恢复对MX的敏感性。倒置显微镜观察细胞形态,发现敲低EpCAM可减少MCF-7/MX细胞间连接。免疫荧光双染法观察到EpCAM与密封蛋白1(claudin 1)在MCF-7/MX细胞共定位;进一步Western 印迹结果表明,敲低EpCAM减少MCF-7/MX细胞中密封蛋白1表达。综上所述,EpCAM可能通过与密封蛋白1相互作用,增强细胞间紧密连接,促进ABCG2介导的乳腺癌多药耐药。     

枯草杆菌耐药转运蛋白Bmr及其基因bmr的表达调控研究进展

枯草杆菌多重耐药转运蛋白Bmr是其主要的耐药外排蛋白之一,由位于基因组DNA的bmr基因编码,介导对多种抗生素、杀菌剂等药物的耐药性。bmr基因的表达受到BmrR及MtaN的转录调控,二者均属于MerR家族调节子。关于近年对多重耐药转运蛋白Bmr和调节蛋白BmrR、MtaN的结构、生理功能及作用机制等研究情况进行综述。     

鲍曼不动杆菌中外排泵介导耐药机制的研究进展

外排泵的过表达是目前导致鲍曼不动杆菌多重耐药的最重要机制之一,详细了解这一复杂机制有助于尽快找到有效的防治策略。目前,鲍曼不动杆菌中已被报道的外排泵家族包括耐药结节细胞分化(resistance-nodulation-cell division,RND)家族、主要协同转运蛋白超家族(major facilitator superfamily,MFS)、多药及毒性化合物外排(multidrug and toxic compound extrusion,MATE)家族、小多重耐药(small multidrug resistance,SMR)家族。它们之中既有通过染色体介导的外排泵,也有通过质粒等遗传元件介导的外排泵。外排底物可呈现多样性,也可呈现专一性。本文就上述外排泵的种类、功能和调控机制进行综述。     

多药耐药基因与子宫颈癌化疗

肿瘤细胞对化疗药物产生多药耐药性是化疗失败的主要原因之一,肿瘤多药耐药的机制十分广泛,其中P-gp/mdrl介导的多药耐药是最经典的耐药机制.故本文就MDR1与宫颈癌化疗的关系进行回顾和总结.     

质膜蛋白与肿瘤多药耐药现象

多药耐药(MDR)是影响肿瘤化疗效果的主要障碍,是由于在耐药细胞质膜上的一系列蛋白是使细胞免受有害因素的攻击。通过30年的研究．证实了肿瘤细胞逃逸化疗药物攻击的许多途径．很显然,多药耐药已经成为肿瘤阻碍各种化疗药物有效治疗的途径。因此．评价肿瘤多药耐药机制及其耐药程度,探讨新的逆转肿瘤多药耐药方法有助于提高化疗效果。本文就MDR中质膜蛋白的分子结构和表型、耐药机制及其逆转方法的研究进展进行综述。     

Acquisition of mitochondrial dysregulation and resistance to mitochondrial-mediated apoptosis after genotoxic insult in normal human fibroblasts: a possible model for early stage carcinogenesis

Acquisition of death-resistance is critical in the evolution of neoplasia. Our aim was to model the early stages of carcinogenesis by examining intracellular alterations in cells that have acquired apoptosis-resistance after exposure to a complex genotoxin. We previously generated sub-populations of BJ-hTERT human diploid fibroblasts, which have acquired death-resistance following exposure to hexavalent chromium [Cr(VI)], a broad-spectrum genotoxicant. Long-term exposure to certain forms of Cr(VI) is associated with respiratory carcinogenesis. Here, we report on the death-sensitivity of subclonal populations derived from clonogenic survivors of BJ-hTERT cells treated with 5 μM Cr(VI) (DR1, DR2), or selected by dilution-based cloning without treatment (CC1). Following Cr(VI) treatment, CC1 cells downregulated expression of the anti-apoptotic protein Bcl-2 and exhibited extensive expression of cleaved caspase 3. In contrast, the DR cells exhibited no cleaved caspase 3 expression and maintained expression of Bcl-2 following recovery from 24 h Cr(VI) exposure. The DR cells also exhibited attenuated mitochondrial-membrane depolarization and mitochondrial retention of cytochrome c and SMAC/DIABLO following Cr(VI) exposure. The DR cells exhibited less basal mtDNA damage, as compared to CC1 cells, which correlates with intrinsic (non-induced) death-resistance. Notably, there was no difference in p53 protein expression before or after treatment among all cell lines. Taken together, our data suggest the presence of more resilient mitochondria in death-resistant cells, and that death-resistance can be acquired in normal human cells early after genotoxin exposure. We postulate that resistance to mitochondrial-mediated cell death and mitochondrial dysregulation may be an initial phenotypic alteration observed in early stage carcinogenesis.     

Acquired TRAIL resistance in human breast cancer cells are caused by the sustained cFLIP(L) and XIAP protein levels and ERK activation

We established TRAIL-resistant MDA-231/TR cells from MDA-231 parent cells to understand the mechanism of TRAIL resistance in breast cancer cells. The selected TRAIL-resistant cells were cross-resistant to TNF-alpha/cycloheximide but remained sensitive to DNA-damage drugs such as oxaliplatin and etoposide. The expression levels of death receptors (DR4 and DR5), FADD, cIAP1, cIAP2, and Bcl-2 family were not changed in TRAIL-treated both cells. Significant down-regulation of XIAP and cFLIP was occurred after TRAIL treatment in MDA-231 cells whereas their levels were sustained in MDA-231/TR cells. TRAIL-mediated activation of ERK and JNK were also observed in parent MDA-231 cells but not in MDA-231/TR cells. However, TRAIL-resistant cells showed constitutive activation state after treatment with TRAIL. Pretreatment with PD98059 or transfection of MKK1-DN (dominant negative) expression vector attenuated TRAIL resistance in MDA-231/TR cells. Our findings provide the evidence that the sustained expression level of cFLIP(L) and XIAP protein and constitutive ERK activation may lead to acquired TRAIL resistance in breast cancer cells.     

LIPOSOMAL DAUNORUBICIN OVERCOMES DRUG RESISTANCE IN HUMAN BREAST,OVARIAN AND LUNG CARCINOMA CELLS

ABSTRACT

Multi-drug resistance due in part to membrane pumps such as P-glycoprotein (Pgp) is a major clinical problem in human cancers. We tested the ability of liposomally-encapsulated daunorubicin (DR) to overcome resistance to this drug. A widely used breast carcinoma cell line originally selected for resistance in doxorubicin (MCF7ADR) was 4-fold resistant to DR compared to the parent MCF7 cells (IC₅₀ 79 nM vs. 20 nM). Ovarian carcinoma cells (SKOV3) were made resistant by retroviral transduction of MDR1 cDNA and selection in vinblastine. The resulting SKOV3MGP1 cells were 130-fold resistant to DR compared to parent cells (IC₅₀ 5700 nM vs. 44 nM). Small-cell lung carcinoma cells (H69VP) originally selected for resistance to etoposide were 6-fold resistant to DR compared to H69 parent cells (IC₅₀ 180 nM vs. 30 nM). In all three cases, encapsulation of DR in liposomes as Daunoxome (Gilead) did not change the IC₅₀ of parent cells relative to free DR. However, liposomal DR overcame resistance in MCF7ADR breast carcinoma cells (IC₅₀ 20 nM), SKOV3MGP1 ovarian carcinoma cells (IC₅₀ 237 nM) and H69VP small-cell lung carcinoma cells (IC₅₀ 27 nM). Empty liposomes did not affect the IC₅₀ for free DR in the three resistant cell lines, nor did empty liposomes affect the IC₅₀ for other drugs that are part of the multi-drug resistance phenotype (etoposide, vincristine) in lung carcinoma cells. These data indicate the possible value of liposomal DR in overcoming Pgp-mediated drug resistance in human cancer.     

植物SAR和ISR中的乙烯信号转导网络

乙烯作为重要的信号分子在植物SAR和ISR中发挥重要作用。受病原物和其它激发子处理后,植物体内乙烯被合成,为内质网上一个His激酶类受体家族(Ⅰ型和Ⅱ型)所感知,在铜离子的转运活性下,乙烯与受体的结合使Raf-类Ser/Thr激酶CTR1失活。在CTR1的下游,EIN2、EIN3、EIN5/AIN1、EIN6、EIN7是乙烯反应的正调节子,负责乙烯信号的传导。EIN2编码功能未知的新的膜整合蛋白,而EIN5/AIN1、EIN6和EIN7尚未从分子水平上进行鉴定。定位在核内的DNA结合蛋白EIN3,直接作用于ERF1,调节乙烯反应基因的转录,激活植物防御素和病程相关蛋白基因的表达,使植物建立抗病性反应。     

一个来自硬粒小麦的抗白粉病基因的鉴定和微卫星标记

在起源于硬粒小麦(TriticumdurumDesf.accessionDR147)和尾状山羊草(AegilopscaudataL.acc.Ae14)合成的双二倍体与普通小麦品种“莱州953”杂交组合衍生的BC3F2群体中鉴定了一个抗小麦白粉病基因。遗传分析表明,该基因为一个显性单基因。应用分离群体分组法(BSA),鉴定了两个与抗病基因紧密连锁的微卫星标记Xgwm311和Xgwm382,它们与抗病基因的遗传距离分别为5.9cM和4.9cM。对双二倍体亲本硬粒小麦DR147和尾状山羊草Ae14及轮回亲本“莱州953”的DNAPCR扩增结果表明,与抗病基因相关的微卫星标记Xgwm311和Xgwm382来源于硬粒小麦DR147。根据已发表的小麦微卫星图谱和对“中国春”缺-四体系DNA扩增结果,抗病基因被定位在小麦2A染色体的长臂末端。     

Knockout of <Emphasis Type="Italic">pprM</Emphasis> Decreases Resistance to Desiccation and Oxidation in <Emphasis Type="Italic">Deinococcus radiodurans</Emphasis>

Deinococcus radiodurans has attracted a great interest in the past decades due to its extraordinary resistance to ionizing radiation and highly efficient DNA repair system. Recent studies indicated that pprM is a putative pleiotropic gene in D. radiodurans and plays an important role in radioresistance and antioxidation, but its underlying mechanisms are poorly elucidated. In this study, pprM mutation was generated to investigate resistance to desiccation and oxidative stress. The result showed that the survival of pprM mutant under desiccation was markedly retarded compared to the wild strain from day 7–28. Furthermore, knockout of pprM increases the intercellular accumulation of ROS and the sensibility to H₂O₂ stress in the bacterial growth inhibition assay. The absorbance spectrum experiment for detecting the carotenoid showed that deinoxanthin, a carotenoid that peculiarly exists in Deinococcus, was reduced in the pprM mutant in the pprM mutant. Quantitative real time PCR showed decreased expression of three genes viz. CrtI (DR0861, 50%),CrtB (DR0862, 40%) and CrtO (DR0093, 50%), which are involved in deinoxanthin synthesis, and of Dps (DNA protection during starving) gene (DRB0092) relevant to ion combining and DNA protection in cells. Our results suggest that pprM may affect antioxidative ability of D. radiodurans by regulating the synthesis of deinoxanthin and the concentration of metal ions. This may provide new clues for the treatment of antioxidants.     

一个来自硬粒小麦的抗白粉病基因的鉴定和微卫星标记

在起源于硬粒小麦(Triticum durum Desf.accession DR147)和尾状山羊草(Aegilops caudata L.acc.Ae14)合成的双二倍体与普通小麦品种"莱州953"杂交组合衍生的BC3F2群体中鉴定了一个抗小麦白粉病基因.遗传分析表明,该基因为一个显性单基因.应用分离群体分组法(BSA),鉴定了两个与抗病基因紧密连锁的微卫星标记Xgwm311和Xgwm382,它们与抗病基因的遗传距离分别为5.9 cM和4.9 cM.对双二倍体亲本硬粒小麦DR147和尾状山羊草Ae14及轮回亲本"莱州953"的DNA PCR扩增结果表明,与抗病基因相关的微卫星标记Xgwm311和Xgwm382来源于硬粒小麦DR147.根据已发表的小麦微卫星图谱和对"中国春"缺-四体系DNA扩增结果,抗病基因被定位在小麦2A染色体的长臂末端.     

植物抗病毒病育种策略

为了得到抗病毒的寄主植物,植物育种学家进行了许多有益研究,形成了许多行之有效的抗病毒病育种策略。利用植物本身对病毒侵染所具有的一些免疫功能及其本身的一些抗性基因来获得抗性;利用来源于病毒自身基因的一些抗病性策略(PDR),如利用病毒外壳蛋白基因,病毒复制酶基因,病毒移动蛋白基因,病毒卫星RNA和反义RNA等,植物也可以获得抗性。近年来对由转录后RNA沉默引起的由RNA介导的病毒抗性策略(RMVR)也进行了深入地研究。除了PDR和RMVR以外,还有一些导致植物抗病毒的策略,包括利用美国商陆的病毒抗性蛋白(PAP),2',5’-寡腺苷酸合成酶,“植物抗体”以及病毒蛋白多肽来获得病毒抗性等。